Sponsor content
844 result(s) found, displaying 491 to 500
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2021
-
Prescription medicine registrationActive ingredients: emtricitabine; tenofovir disoproxil fumarate.
-
Prescription medicine registrationActive ingredients: paclitaxel.
-
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 18/09/2020
-
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 18/09/2020
-
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 18/09/2020
-
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 18/09/2020
-
PHARMACY CHOICE ANTISEPTIC CREAM tube (Cancelled from the ARTG under subsection 30(2)(a) of the Act)
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 18/09/2020 -
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 18/09/2020